CD209 and neoplasm: In addition, through DC‐SIGN, DNGR‐1 and DEC‐205 with appropriate adjuvants to target the delivery of tumour antigens can prevent the development of tumours or mediated eradication in transplanted mouse models.9, 35, 36, 37